Associate Director, Medical Affairs (Medical Science Liaison) – Southeast Region at Iovance Biotherapeutics

Job description

About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com . Overview The Associate Director, Medical Affairs (Medical Science Liaison) is a field-based individual contributor who advances the medical strategy for Iovance’s developmental and marketed products through high-impact scientific exchange, generation and communication of actionable medical insights, and cross-functional partnership. This role builds and sustains relationships with regional and national external experts (e.g., key opinion leaders, investigators, and healthcare systems) and supports clinical trial site identification and execution, consistent with applicable laws, regulations, and company policies. The Associate Director operates with a high degree of independence, provides scientific and strategic input to internal teams, and contributes to consistent field medical standards and processes through collaboration and sharing of best practices (without direct people-management responsibility). Region : Southeast (Florida (preferred), Georgia, South Carolina, or Alabama) Essential Functions and Responsibilities Advance the medical strategy within the assigned territory by delivering fair-balanced, evidence-based scientific exchange and by representing Iovance as a credible partner to the healthcare community Deliver high-quality scientific and clinical presentations on disease state(s) and Iovance products (approved and pipeline) to internal and external audiences; tailor content to audience needs and ensure alignment with approved materials and compliance requirements Identify, map, and profile external experts (e.g., KOLs, investigators, advocacy and healthcare system stakeholders) and develop territory engagement plans to inform medical priorities and scientific collaboration opportunities Develop and sustain relationships with healthcare professionals and clinical investigators in academic and community settings to support scientific activities aligned with the medical plan (e.g., publications, advisory boards, investigator-initiated research support, and clinical trials, as applicable) Collect, synthesize, and communicate high-quality field medical insights using approved tools and processes; identify trends, elevate insights to internal stakeholders, and contribute to insight-to-action discussions Provide scientific support for Medical Affairs activities and scientific sessions at key congresses/meetings; plan and execute congress engagement in coordination with internal stakeholders Build strong cross-functional partnerships (e.g., Medical Affairs, Clinical Science, Clinical Operations, Market Access, and Commercial) to ens